FIA
VAXX

FNY Investment Advisers’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

FNY Investment Advisers’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,000
Closed -$17K – 897
2022
Q2 		$17K Buy
11,000
+10,952
+22,817% +$41.4K 0.01% 353
2022
Q1 		$0 Sell
48
-4,799
-99% -$26.5K ﹤0.01% 967
2021
Q4 		$27K Buy
+4,847
New +$50.1K 0.01% 304

Other funds holding VAXX

PML
Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FNY Investment Advisers's VAXX Position: Q3 2022 in Review

FNY Investment Advisers sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q3 2022, closing a stake of 11,000 shares — an estimated $17K sold.

FNY Investment Advisers first reported a position in VAXX in Q4 2021 and held it in 3 quarters. The position peaked at $27K in Q4 2021. 29 funds tracked by Wall St. Rank hold VAXX as of Q3 2022.

  • FNY Investment Advisers reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 11,000 Vaxxinity, Inc. Class A Common Stock shares in Q3 2022, an estimated $17K.
  • FNY Investment Advisers first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • FNY Investment Advisers's Vaxxinity, Inc. Class A Common Stock position peaked at $27K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.